Plaque reduction assay Accueil Human and animal health In vitro/ex vivo testing Virus/antibody related assay Plaque reduction assay In vitro/ex vivo testing Virus/antibody related assay Our models for Human and animal health In vitro/ex vivo cytotoxicity Assessment of the cytotoxic activity of a compound on a model of the human alveolar tissue Assessment of the cytotoxic and anti-infective activity of compounds using human lung organoid models In vivo safety Maximum tolerated dose (MTD) / tolerability assay for Preclinical Research Pharmacokinetics (PK) assay for Preclinical Research In vitro/ex vivo testing Antiviral drug screening evaluation Elisa Based assays Virus/antibody related assay Plaque reduction assay Antibacterial and antifungal Assessment of the anti-biofilm activity of an anti-infective molecule Assessment of the antibacterial activity of an anti-infective molecule on persister cells Determination of the resistance development against an antibacterial compound Development of ELISAs in the context of a vaccine program against Candida albicans Evaluation of bacterial susceptibility to bacteriophages Mechanism of action of an antibacterial compound : impact on the bacterial envelop integrity Quantification of intracellular bacteria Role of microbial-derived extracellular vesicles in pathophysiology Time kill Curve (TKC) In vivo infection Bacterial/fungal Gastrointestinal Infection Models for Preclinical Research Pulmonary Infection Models for Preclinical Research Septicemia Models for Preclinical Research Skin Infection Models for Preclinical Research Thigh Infection Models for Preclinical Research Urinary Tract Infection Models for Preclinical Research Viral Viral Infection Models for Preclinical Research Viral Septicemia Models for Preclinical Research Quickly qualify your study needs Go !
